Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 61
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

A synthetic chronogenetic gene circuit for programmed circadian drug delivery

A synthetic chronogenetic gene circuit for programmed c...

 72

Microglial ER Stress Response via IRE1α Regulates Diet-Induced Metabolic Imbalance and Obesity in Mice

Microglial ER Stress Response via IRE1α Regulates Diet-...

 104

Membrane-permeable trehalose 6-phosphate precursor spray increases wheat yields in field trials

Membrane-permeable trehalose 6-phosphate precursor spra...

 58